Ocular Distribution of Brimonidine and Brinzolamide after Topical Instillation of a 0.1% Brimonidine Tartrate and 1% Brinzolamide Fixed-Combination Ophthalmic Suspension: An Interventional Study

Ocular Distribution of Brimonidine and Brinzolamide after Topical Instillation of a 0.1% Brimonidine Tartrate and 1% Brinzolamide Fixed-Combination Ophthalmic Suspension: An Interventional Study

Purpose: To evaluate the concentrations of brimonidine and brinzolamide in the vitreous and aqueous humor after instillation of a 0.1% brimonidine tartrate and 1% brinzolamide fixed-combination ophthalmic suspension. Methods: The present investigation involved patients with macular holes or idiopath...

Full description

Bibliographic Details
Main Authors:	Yusuke Orii, Eriko Kunikane, Yutaka Yamada, Masakazu Morioka, Kentaro Iwasaki, Shogo Arimura, Akemi Mizuno, Masaru Inatani
Format:	Article
Language:	English
Published:	MDPI AG 2023-06-01
Series:	Journal of Clinical Medicine
Subjects:	brimonidine brinzolamide fixed-combination ophthalmic suspension vitreous humors aqueous humors
Online Access:	https://www.mdpi.com/2077-0383/12/13/4175

Similar Items

The Efficacy, Safety, and Satisfaction Associated with Switching from Brinzolamide or Brimonidine to Brinzolamide/Brimonidine in Open-Angle Glaucoma Patients
by: Hiromitsu Onoe, et al.
Published: (2022-12-01)

The Efficacy, Safety and Satisfaction Associated with Switching from Brinzolamide 1% and Brimonidine 0.1% to a Fixed Combination of Brinzolamide 1% and Brimonidine 0.1% in Glaucoma Patients
by: Hiromitsu Onoe, et al.
Published: (2021-11-01)

Brinzolamide/Brimonidine Fixed Combination: Simplifying Glaucoma Treatment Regimens
by: Reza Moosavi, et al.
Published: (2018-10-01)

Evaluation of the Use of Brinzolamide-Brimonidine Fixed Combination in Maximum Medical Therapy
by: Oya Tekeli, et al.
Published: (2022-08-01)

Comparison of the Intraocular Pressure-Lowering Efficacy and Safety of the Brinzolamide/Brimonidine Fixed-Dose Combination versus Concomitant Use of Brinzolamide and Brimonidine for Management of Open-Angle Glaucoma or Ocular Hypertension
by: Wang N, et al.
Published: (2020-01-01)

The chemotactic properties of various topical brimonidine tartrate ophthalmic preparations
by: Ruiz Simonato Alonso, et al.
Published: (2020-03-01)

Brimonidine and timolol concentrations in the human vitreous and aqueous humors after topical instillation of a 0.1% brimonidine tartrate and 0.5% timolol fixed-combination ophthalmic solution: An interventional study.
by: Yusuke Orii, et al.
Published: (2022-01-01)

Brimonidine and timolol concentrations in the human vitreous and aqueous humors after topical instillation of a 0.1% brimonidine tartrate and 0.5% timolol fixed-combination ophthalmic solution: An interventional study
by: Yusuke Orii, et al.
Published: (2022-01-01)

Maximum Medical Therapy: Brinzolamide/Brimonidine And Travoprost/Timolol Fixed-Dose Combinations In Glaucoma And Ocular Hypertension
by: Lerner SF, et al.
Published: (2019-12-01)

Effect of brimonidine tartrate on basophil activation in glaucoma patients
by: Eldar Rosenfeld, et al.
Published: (2020-03-01)

First-order derivative spectrophotometric method for simultaneous determination of brinzolamide and timolol maleate in ophthalmic formulation
by: Srushti Tambe, et al.
Published: (2024-03-01)

Ocular and Systemic Pharmacokinetics of Brimonidine and Timolol After Topical Administration in Rabbits: Comparison Between Fixed-Combination and Single Drugs
by: Gen Suzuki, et al.
Published: (2020-01-01)

Patient Factors Influencing Intraocular Penetration of Brimonidine-Related Eye Drops in Adults: A Post Hoc Pooled Analysis
by: Eriko Kunikane, et al.
Published: (2023-09-01)

Pharmacodynamic approach for proving equivalence of two ophtalmic solutions containing Brimonidine Tartarate 0.2% in healthy volunteers
by: Hristova-Valcheva Ruska, et al.
Published: (2018-01-01)

The effect of a brinzolamide/brimonidine fixed combination on optic nerve head blood flow in rabbits.
by: Nana Takahashi, et al.
Published: (2023-01-01)

The effect of a brinzolamide/brimonidine fixed combination on optic nerve head blood flow in rabbits
by: Nana Takahashi, et al.
Published: (2023-01-01)

Neuroprotective properties of Brimonidine
by: Т. N. Mikhailova
Published: (2019-11-01)

Preparation and Characterization of Ion-Sensitive Brimonidine Tartrate In Situ Gel for Ocular Delivery
by: Haonan Xu, et al.
Published: (2023-01-01)

Comparative study of brimonidine and timolol in treatment of glaucoma
by: Jagadish Chandrarao Narasaiah Lakkineni
Published: (2015-01-01)

Effects of brimonidine tartrate 0.2 and 0.15% ophthalmic solution on the static and dynamic pupil characteristics
by: Jing Yang, et al.
Published: (2023-05-01)

Difference in vasoconstrictors: oxymetazoline vs. brimonidine
by: Nwanneka Okwundu, et al.
Published: (2021-02-01)

Brimonidine-associated uveitis – a descriptive case series
by: Susanne Hopf, et al.
Published: (2020-12-01)

Switching to Brimonidine/Ripasudil Fixed Combination from Brimonidine + Ripasudil
by: Inoue K, et al.
Published: (2024-02-01)

Recent overviews on the drug delivery aspects and applications of brinzolamide for the management of glaucoma
by: Yash Sharma, et al.
Published: (2023-03-01)

Brimonidine as a possible treatment for myopia
by: Zixuan Peng, et al.
Published: (2024-04-01)

Apraclonidine versus brinzolamide-timolol combination to prevent intraocular pressure elevation after laser capsulotomy
by: Erkan Çelik, et al.
Published: (2016-01-01)

Prolonged central nervous system and respiratory depression in preterm neonates after exposure to brimonidine tartrate and timolol maleate ophthalmic drops
by: Azarcon, Corrina P., et al.
Published: (2020-05-01)

Brinzolamide/timolol versus dorzolamide/timolol fixed combinations: A hospital-based, prospective, randomized study
by: Mary S Galose, et al.
Published: (2016-01-01)

Comparative Analysis of Pupil Diameters in Light and Dark Conditions After Instillation of 0.15% Brimonidine Drops in Eyes With and Without Pseudoexfoliation Syndrome
by: Sercan Cate, et al.
Published: (2020-12-01)

Nummular keratitis: A rare manifestation of brimonidine allergy
by: Maitha Al Asmi, et al.
Published: (2024-01-01)

Effects of brinzolamide on rabbit ocular blood flow in vivo and ex vivo
by: Ya-Ru Dong, et al.
Published: (2018-05-01)

Effect of 1% brinzolamide and 0.5% timolol fixed combination on intraocular pressure after cataract surgery with phacoemulsification
by: Kemal Örnek, et al.
Published: (2013-12-01)

Efficacy of Topical Brinzolamide Treatment in Posterior Microphthalmos- Related Macular Cystoid Lesions: A Case Series
by: Ceren Durmaz Engin, et al.
Published: (2020-01-01)

Topical brimonidine for pyogenic granuloma after paronychia surgery
by: Yusha Chen, MM, et al.
Published: (2021-01-01)

Augmented in vitro and in vivo Profiles of Brimonidine Tartrate Using Gelatinized-Core Liposomes
by: Abdel Azim EA, et al.
Published: (2022-06-01)

Co-delivery of brinzolamide and miRNA-124 by biodegradable nanoparticles as a strategy for glaucoma therapy
by: Tingting Li, et al.
Published: (2020-01-01)

Efficacy and safety of various brimonidine formulations in the treatment of glaucoma and ocular hypertension
by: A. V. Sidorova, et al.
Published: (2021-07-01)

Active Pharmacovigilance in Peruvian Population: Surveillance of a Timolol/Brimonidine/Dorzolamide Ophthalmic Fixed Combination
by: Contreras-Salinas H, et al.
Published: (2021-02-01)

About the pathways to deliver brimonidine to the Muller’s muscle
by: Soha Ghanian, MD, et al.
Published: (2023-03-01)

A validated stability-indicating HPLC method for determination of brimonidine tartrate in BRI/PHEMA drug delivery systems
by: Jianguo Sun, et al.
Published: (2017-07-01)